Navigation Links
FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation
Date:12/14/2008

is an intravenous sedative-hypnotic agent indicated for monitored anesthesia care (MAC) sedation in adult patients undergoing diagnostic or therapeutic procedures.

Important Safety Information

LUSEDRA should be administered only by persons trained in the administration of general anesthesia and not involved in the conduct of the diagnostic or therapeutic procedure. Patients should be continuously monitored during sedation and through the recovery process for early signs of hypotension, apnea, airway obstruction, and/or oxygen desaturation. Facilities for providing cardiopulmonary resuscitation must be immediately available.

The following serious adverse reactions have been reported with the use of LUSEDRA.

    -- Hypotension
       -- Hypotension was reported in 18/455 (4%) patients treated with
          LUSEDRA using the standard or modified dosing regimen.
       -- Patients with compromised myocardial function, reduced vascular
          tone, or who have reduced intravascular volume may be at an
          increased risk for hypotension.

    -- Hypoxemia
       -- Hypoxemia was reported in 20/455 (4%) patients treated with LUSEDRA
          using the standard or modified dosing regimen. Retention of
          purposeful responsiveness did not prevent patients from becoming
          hypoxemic following administration of LUSEDRA.

    -- Respiratory depression
       -- Apnea was reported in 1/455 (< 1%) patients treated with LUSEDRA
          using the standard or modified dosing regimen.

    -- Loss of purposeful responsiveness
       -- LUSEDRA has not been studied for use in general anesthesia. However,
          administration of LUSEDRA may inadvertently cause patients to become
          unresponsive or minimally responsive to vigorous tactile or painful
          stimulation. The incidence of patients who became minimally
          responsive or unresponsive to vigo
'/>"/>
SOURCE Eisai Corporation of North America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
2. FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder
3. FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
4. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
5. F.D.A. Approves SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy
6. FDA Approves First Hepatitis B Viral Load Test
7. U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinsons Disease
8. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
9. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
10. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
11. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... NEW YORK, Nov. 25 Reportlinker.co...vailable in its catalogue: ,, Mammography Equ...://www.reportlinker.com/p0164330/Mammography-Equip...ing incidence of breast cancer in industrialized a... influencing growth in the mammography market. Glo...
(Date:11/25/2009)..., SAN DIEGO, Nov. 25 Nu...mpany focused on developing products for minimally...ounced today that it will host a conference call o...0 p.m. PT. The conference call will focus on curr...ny,s products and will include comments from manag...
(Date:11/25/2009)... DELFT, The Netherlands and JOHANNESBURG, Novembe...ice division and Pyxis Discovery announced today,t...jointly market both,companies, services. , ...lead discovery expertise,will be coupled with iThe...nthetic chemistry support to projects identified t...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Tubal Reversal Surgeons Reverse Adiana Sterilization 59262 1New strategy for mending broken hearts 3F 10316 1New strategy for mending broken hearts 3F 10316 2NHC Group CEO Paul Mirabelle Announces National Hearing Care 26apos 3Bs Proposal to Buy Bay Audiology Approved 59256 1
(Date:11/27/2009)... Three new interactive an...Williams & Wilkins expand health sciences lear... Durham, NC (Vocus) November ...ms & Wilkins (LWW), a division of Wolters Kluw...ee new anatomy education apps on the App Store. Cl...
(Date:11/26/2009)... In the next 25 years, the number of Americans li...from 23.7 million in 2009 to 44.1 million in 2034....lmost triple, rising from $113 billion to $336 bil...besity, researchers based at the University of Chi...e . , The number of those with diabetes covered ...
(Date:11/26/2009)...Fans get a bigger thrill when on an emotional roll.... 26 (HealthDay News) -- Call it the fear factor m...gests that spectators -- especially those who root...action if it,s a closely contested match and victo...ven despair. , Chew on that this Thanksgiving w...
(Date:11/26/2009)... Research Triangle Dental...ntral North Carolina, today announced the expansio...ied LUMINEER Dentist, Dr. Doug Macmillan. , ...ch Triangle Dental is pleased to announce that Dr....t, recently completed an additional advanced train...
(Date:11/25/2009)..., , EDINA, Minn., Nov. 25 /PRNewswire-USNe...they think of their dentist. But a chiropractor c...ds for the Temporal-Mandibular Joint, which is whe... skull (temporal bone). ,, The most common sym...h chewing, clicking or popping of the jaw. But ma...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...Focuses on the Importance of Physical Activity for...CRAMENTO, Calif., Oct. 22 For the nearly 100 mill...l activity must be a crucial,component to weight l...a,s,Health, a research group that focuses on disea...
...22 American National,Insurance Company (Nasdaq: ...$79,244,000 ($2.98 per diluted share) compared to ... period in 2006. After tax operating earnings for... increase. After tax operating,earnings exclude af...
...Aware, a leading supplier of,innovative services t... of,SleepAware, the newest module in the Company,s...eaking system that identifies at-risk patients,wit...,s mission of,promoting early detection and preven...
...7 The Journal of the American Dental Association ...urnals today in publishing a global theme issue on...ollaborative effort among the worlds biomedical pu...e world of articles on povertys devastating effect...
...kland, CA) Electronic medical records and outreach...lls to patients and their primary care providers a...diagnosis and management of the patients osteoporo...w that electronic medical records improve the cont...
...tober 22, 2007 Human Resources for Treating HIV/AI...oday in AIDS Patient Care and STDs has been select...he NIH Launch of the Council of Science Editors Gl...ss and stimulate dialogue to address this worldwid...
Other Medicine News:Health News:This October, the American Physical Therapy Association's National Physical Therapy Month to Focus on Nation's Obesity Epidemic 2Health News:This October, the American Physical Therapy Association's National Physical Therapy Month to Focus on Nation's Obesity Epidemic 3Health News:This October, the American Physical Therapy Association's National Physical Therapy Month to Focus on Nation's Obesity Epidemic 4Health News:American National Announces Third Quarter 2007 Results 2Health News:American National Announces Third Quarter 2007 Results 3Health News:American National Announces Third Quarter 2007 Results 4Health News:HealthAware Introduces Its SleepAware Cardiovascular Disease Module 2Health News:Journal of the American Dental Association spotlights poverty 2Health News:Kaiser Permanente study shows electronic medical records and outreach improve osteoporosis care 2Health News:Kaiser Permanente study shows electronic medical records and outreach improve osteoporosis care 3
...ple technologies to bring new automated parameters...on of RNA allows for fully-automated, random-acces...f nucleated red blood cells ensures accurate white...count. Two-dimensional Optical platelet counts wit...
...fferential analyzer based on the proven technology...ering 18 parameters and extensive QC and data mana...eeds to today's growing labs. The CELL-DYN 1800 is...dard physician office laboratory cabinets. The sys...
...s hematology needs in today's changing laboratory ...tube sampling, small sample requirements, and high...ematology lab. New challenges have made fast acces...implification of data interpretation necessary to ...
Precision Net
Medicine Products: